Nicholas Thomas Mcbride, DPT | |
6500 Byron Center Ave Sw Ste 202, Byron Center, MI 49315-9083 | |
(616) 249-0750 | |
(616) 249-0794 |
Full Name | Nicholas Thomas Mcbride |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 6500 Byron Center Ave Sw Ste 202, Byron Center, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851870299 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 5501016868 (Michigan) | Secondary |
225100000X | Physical Therapist | 5501016868 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nicholas Thomas Mcbride, DPT 2224 Vansingel Lake Dr Sw, Byron Center, MI 49315-8091 Ph: (616) 822-7890 | Nicholas Thomas Mcbride, DPT 6500 Byron Center Ave Sw Ste 202, Byron Center, MI 49315-9083 Ph: (616) 249-0750 |
News Archive
Blood sugar surges - after-meal glucose "spikes" - can be life threatening for the 29 million Americans with diabetes. Diabetic blood sugar spikes have been linked to cardiovascular disease, cancer, Alzheimer's disease, kidney failure, and retinal damage.
The St. Baldrick's Foundation, a volunteer-driven and donor-centered charity dedicated to raising money for childhood cancer research, has awarded a one-year, $50,000 grant to the University of Louisville (UofL).
Intradigm Corporation announced today its collaboration with Chinese academic and biotech groups has achieved clear evidence of prophylactic and therapeutic effects of siRNA (small interfering RNA) agents in Rhesus monkey to treat SARS coronavirus (SCV) respiratory infection.
Belmont, MA-Researchers at Harvard Affiliated McLean Hospital have been awarded a $1.9 million National Institutes of Health Director's Opportunity Award to continue their research into creating human induced pluripotent (iPS) stem cells using a method aimed at eliminating the risk of cancer and other problems associated with other options such as genome-integrating viral methods.
A human DNA-associated protein called LEDGF is the first such molecule found to control the location of HIV integration in human cells, according to researchers at the University of Pennsylvania School of Medicine.
› Verified 7 days ago